Editor’s Note February 21, 2012

In this week’s Sentinel:

Peter Winter continues to bring us financings and developments in the global diagnostics business. BIO CEO & Investor Conference 2012, held last week in New York City, proved itself one of the most important in the healthcare industry. Intellect Neurosciences, Inc. (OTCBB:ILNS) files new patent applications in the treatment of Alzheimer’s Disease.  The CEO of Spherix [SPEX] discusses definitive agreements to sell $1.15 million in common stock and warrants.  Contrast-induced nephropathy (CIN), a form of acute renal failure is linked to mortality in hospital patients.

 

Sincerely,

Brett Johnson

The comments are closed.